(PharmaNewsWire.Com, February 27, 2019 ) The Multiplex Assays Market report is a combination of qualitative as well as quantitative analysis which can be broken down into 40% and 60% respectively. Market estimation and forecasts are presented in the report for the overall global market from 2019 – 2027, considering 2019 as the base year and 2019 – 2027 forecast period. Global estimation is further broken down by segments and geographies such as North America, Europe, Asia-Pacific, Middle East & Africa and South America covering major 16 countries across the mentioned regions.
The "Global Multiplex Assays Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a focus on the global market trend. The report aims to provide an overview of global multiplex assays market with detailed market segmentation by product, type, technology, end user and geography. The global multiplex assays market is expected to increase the high progression during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.
The multiplex assays market is classified by product as consumables, instruments and software. By type, the multiplex assays market is segmented as protein multiplex assays, nucleic acid multiplex assays and cell-based multiplex assays. By technology the multiplex assays market is segmented into flow cytometry, fluorescence detection, luminescence, multiplex real-time PCR and others. The application segment is further sub-segmented into research & development and clinical diagnostics. On basis of end user the multiplex assays market is segmented into pharmaceutical & biotechnology companies, hospitals, diagnostic laboratories and others.
The List of Companies
1. Thermo Fisher Scientific Inc. 2. Illumina Inc 3. Bio-Rad Laboratories, Inc. 4. Qiagen 5. Abcam plc 6. BD 7. Agilent Technologies, inc. 8. Quanterix, 9. Bio-Techne 10. Seegene Inc.
The Multiplex Assays Marketreport provides a detailed overview on the industry including both qualitative and quantitative information. It provides overview and forecast of the global multiplex assays market based product, type, technology, end user. It also provides market size and forecast till 2027 for overall multiplex assays market with respect to five major regions, namely; North America, Asia-Pacific (APAC), Europe, Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.
North America is expected to gain the largest share of the global multiplex assays market, due to government support for the development of advanced technologies for diagnostics, availability of skilled healthcare professionals and growing adoption of advanced techniques for research are some of the factors anticipated to boost the regional market growth. While the Asia Pacific region is expected to possess potential market due to establishment of various biotechnological companies, particularly in India and China will fuel demand in this region. The presence of untapped opportunities, continuously growing healthcare infrastructure, and economic development, are some of the factors accounting for the rapid growth of multiplex assays market in this region.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
